HALO logo

Halozyme Therapeutics, Inc. (HALO) Cost of goods sold

annual cost of goods sold:

$230.47M-$35.67M(-13.40%)
December 31, 2024

Summary

  • As of today (September 5, 2025), HALO annual cost of goods sold is $230.47 million, with the most recent change of -$35.67 million (-13.40%) on December 31, 2024.
  • During the last 3 years, HALO annual cost of goods sold has risen by +$149.05 million (+183.08%).
  • HALO annual cost of goods sold is now -13.40% below its all-time high of $266.13 million, reached on December 31, 2023.

Performance

HALO Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

quarterly cost of goods sold:

$64.12M-$2.04M(-3.09%)
June 30, 2025

Summary

  • As of today (September 5, 2025), HALO quarterly cost of goods sold is $64.12 million, with the most recent change of -$2.04 million (-3.09%) on June 30, 2025.
  • Over the past year, HALO quarterly cost of goods sold has increased by +$6.75 million (+11.77%).
  • HALO quarterly cost of goods sold is now -14.69% below its all-time high of $75.16 million, reached on September 30, 2023.

Performance

HALO quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

TTM cost of goods sold:

$257.29M+$6.75M(+2.69%)
June 30, 2025

Summary

  • As of today (September 5, 2025), HALO TTM cost of goods sold is $257.29 million, with the most recent change of +$6.75 million (+2.69%) on June 30, 2025.
  • Over the past year, HALO TTM cost of goods sold has increased by +$8.61 million (+3.46%).
  • HALO TTM cost of goods sold is now -3.32% below its all-time high of $266.13 million, reached on December 31, 2023.

Performance

HALO TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

HALO Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.4%+11.8%+3.5%
3 y3 years+183.1%+41.4%+153.6%
5 y5 years+406.0%+1017.1%+409.0%

HALO Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.4%+183.1%-14.7%+41.4%-3.3%+153.6%
5 y5-year-13.4%+431.4%-14.7%+1051.6%-3.3%+661.6%
alltimeall time-13.4%>+9999.0%-14.7%>+9999.0%-3.3%>+9999.0%

HALO Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$64.12M(-3.1%)
$257.29M(+2.7%)
Mar 2025
-
$66.17M(+10.6%)
$250.54M(+8.7%)
Dec 2024
$230.47M(-13.4%)
$59.82M(-11.0%)
$230.47M(-4.3%)
Sep 2024
-
$67.19M(+17.1%)
$240.71M(-3.2%)
Jun 2024
-
$57.37M(+24.5%)
$248.69M(-4.1%)
Mar 2024
-
$46.09M(-34.2%)
$259.22M(-2.6%)
Dec 2023
$266.13M(+45.9%)
$70.06M(-6.8%)
$266.13M(+9.6%)
Sep 2023
-
$75.16M(+10.7%)
$242.75M(+0.3%)
Jun 2023
-
$67.91M(+28.1%)
$242.09M(+10.3%)
Mar 2023
-
$53.01M(+13.6%)
$219.53M(+20.3%)
Dec 2022
$182.45M(+124.1%)
$46.67M(-37.4%)
$182.45M(+15.9%)
Sep 2022
-
$74.51M(+64.3%)
$157.37M(+55.1%)
Jun 2022
-
$45.35M(+184.8%)
$101.44M(+28.2%)
Mar 2022
-
$15.92M(-26.2%)
$79.12M(-2.8%)
Dec 2021
$81.41M(+87.7%)
$21.59M(+16.1%)
$81.41M(-5.4%)
Sep 2021
-
$18.59M(-19.2%)
$86.10M(+17.8%)
Jun 2021
-
$23.02M(+26.3%)
$73.08M(+31.0%)
Mar 2021
-
$18.22M(-30.7%)
$55.80M(+28.7%)
Dec 2020
$43.37M(-4.8%)
$26.27M(+371.8%)
$43.37M(+28.4%)
Sep 2020
-
$5.57M(-3.0%)
$33.78M(-33.2%)
Jun 2020
-
$5.74M(-0.8%)
$50.55M(+6.0%)
Mar 2020
-
$5.79M(-65.3%)
$47.68M(+2.4%)
Dec 2019
$45.55M(+349.3%)
$16.69M(-25.3%)
$46.55M(+31.2%)
Sep 2019
-
$22.33M(+676.3%)
$35.48M(+157.6%)
Jun 2019
-
$2.88M(-38.1%)
$13.77M(+17.4%)
Mar 2019
-
$4.65M(-17.3%)
$11.73M(+15.8%)
Dec 2018
$10.14M(-67.5%)
$5.62M(+798.1%)
$10.14M(-15.5%)
Sep 2018
-
$626.00K(-25.1%)
$12.00M(-39.1%)
Jun 2018
-
$836.00K(-72.6%)
$19.71M(-26.1%)
Mar 2018
-
$3.05M(-59.2%)
$26.66M(-14.4%)
Dec 2017
$31.15M(-6.2%)
$7.49M(-10.1%)
$31.15M(-1.6%)
Sep 2017
-
$8.33M(+7.0%)
$31.67M(-2.5%)
Jun 2017
-
$7.79M(+3.2%)
$32.47M(-1.6%)
Mar 2017
-
$7.54M(-5.7%)
$32.99M(-0.7%)
Dec 2016
$33.21M(+13.5%)
$8.00M(-12.4%)
$33.21M(-1.3%)
Sep 2016
-
$9.13M(+9.9%)
$33.63M(+9.6%)
Jun 2016
-
$8.31M(+7.0%)
$30.68M(+0.5%)
Mar 2016
-
$7.76M(-7.9%)
$30.51M(+4.3%)
Dec 2015
$29.25M(+28.7%)
$8.43M(+36.4%)
$29.25M(+8.5%)
Sep 2015
-
$6.18M(-24.1%)
$26.96M(+4.0%)
Jun 2015
-
$8.14M(+25.4%)
$25.93M(+9.4%)
Mar 2015
-
$6.49M(+5.6%)
$23.71M(+4.3%)
Dec 2014
$22.73M(+264.0%)
$6.15M(+19.6%)
$22.73M(+13.0%)
Sep 2014
-
$5.14M(-13.2%)
$20.13M(+28.5%)
Jun 2014
-
$5.92M(+7.3%)
$15.67M(+42.1%)
Mar 2014
-
$5.52M(+55.9%)
$11.03M(+76.5%)
Dec 2013
$6.25M
$3.54M(+418.5%)
$6.25M(+71.5%)
DateAnnualQuarterlyTTM
Sep 2013
-
$682.70K(-46.8%)
$3.64M(+4.9%)
Jun 2013
-
$1.28M(+73.7%)
$3.47M(+33.4%)
Mar 2013
-
$739.00K(-21.1%)
$2.60M(+19.8%)
Dec 2012
$2.17M(+60.6%)
$937.10K(+82.7%)
$2.17M(-86.8%)
Sep 2012
-
$512.80K(+23.5%)
$16.45M(+1.6%)
Jun 2012
-
$415.30K(+34.6%)
$16.19M(-0.3%)
Mar 2012
-
$308.60K(-98.0%)
$16.24M(-0.2%)
Dec 2011
$1.35M(-45.7%)
$15.22M(+5976.9%)
$16.27M(+611.7%)
Sep 2011
-
$250.40K(-46.2%)
$2.29M(-5.0%)
Jun 2011
-
$465.20K(+37.7%)
$2.41M(-0.3%)
Mar 2011
-
$337.90K(-72.6%)
$2.42M(-3.1%)
Dec 2010
$2.49M(+42.0%)
$1.23M(+231.6%)
$2.49M(+37.3%)
Sep 2010
-
$371.70K(-21.4%)
$1.82M(-5.2%)
Jun 2010
-
$472.90K(+13.7%)
$1.92M(+4.2%)
Mar 2010
-
$415.90K(-25.1%)
$1.84M(+4.7%)
Dec 2009
$1.76M(+27.2%)
$555.10K(+17.8%)
$1.76M(+8.5%)
Sep 2009
-
$471.10K(+18.8%)
$1.62M(+3.8%)
Jun 2009
-
$396.50K(+19.1%)
$1.56M(+7.7%)
Mar 2009
-
$332.80K(-20.4%)
$1.45M(+4.9%)
Dec 2008
$1.38M(+69.0%)
$418.10K(+1.7%)
$1.38M(+14.5%)
Sep 2008
-
$411.20K(+44.0%)
$1.20M(+19.7%)
Jun 2008
-
$285.50K(+7.6%)
$1.01M(+9.5%)
Mar 2008
-
$265.40K(+9.3%)
$919.40K(+12.5%)
Dec 2007
$816.90K(+20.0%)
$242.80K(+14.2%)
$816.90K(+18.9%)
Sep 2007
-
$212.60K(+7.0%)
$686.80K(-23.1%)
Jun 2007
-
$198.60K(+21.9%)
$893.40K(+16.3%)
Mar 2007
-
$162.90K(+44.5%)
$768.00K(+12.8%)
Dec 2006
$681.00K(+163.6%)
$112.70K(-73.1%)
$681.00K(+6.3%)
Sep 2006
-
$419.20K(+472.7%)
$640.40K(+132.7%)
Jun 2006
-
$73.20K(-3.6%)
$275.20K(-3.1%)
Mar 2006
-
$75.90K(+5.3%)
$284.00K(+10.0%)
Dec 2005
$258.30K(>+9900.0%)
$72.10K(+33.5%)
$258.20K(+14.6%)
Sep 2005
-
$54.00K(-34.1%)
$225.40K(+10.5%)
Jun 2005
-
$82.00K(+63.7%)
$204.00K(+34.3%)
Mar 2005
-
$50.10K(+27.5%)
$151.90K(+23.2%)
Dec 2004
$0.00(-100.0%)
$39.30K(+20.6%)
$123.30K(+25.8%)
Sep 2004
-
$32.60K(+9.0%)
$98.00K(+31.7%)
Jun 2004
-
$29.90K(+39.1%)
$74.40K(+64.6%)
Mar 2004
-
$21.50K(+53.6%)
$45.20K(+84.5%)
Dec 2003
$27.00K(-45.7%)
$14.00K(+55.6%)
$24.50K(-47.1%)
Sep 2003
-
$9000.00(+1185.7%)
$46.30K(+13.2%)
Jun 2003
-
$700.00(-12.5%)
$40.90K(-14.3%)
Mar 2003
-
$800.00(-97.8%)
$47.70K(-4.0%)
Dec 2002
$49.70K(+212.6%)
$35.80K(+894.4%)
$49.70K(+257.6%)
Sep 2002
-
$3600.00(-52.0%)
$13.90K(+35.0%)
Jun 2002
-
$7500.00(+167.9%)
$10.30K(+267.9%)
Mar 2002
-
$2800.00
$2800.00
Dec 2001
$15.90K
-
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual cost of goods sold year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly cost of goods sold year-on-year change?
  • What is Halozyme Therapeutics, Inc. TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. TTM cost of goods sold year-on-year change?

What is Halozyme Therapeutics, Inc. annual cost of goods sold?

The current annual cost of goods sold of HALO is $230.47M

What is the all time high annual cost of goods sold for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual cost of goods sold is $266.13M

What is Halozyme Therapeutics, Inc. annual cost of goods sold year-on-year change?

Over the past year, HALO annual cost of goods sold has changed by -$35.67M (-13.40%)

What is Halozyme Therapeutics, Inc. quarterly cost of goods sold?

The current quarterly cost of goods sold of HALO is $64.12M

What is the all time high quarterly cost of goods sold for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly cost of goods sold is $75.16M

What is Halozyme Therapeutics, Inc. quarterly cost of goods sold year-on-year change?

Over the past year, HALO quarterly cost of goods sold has changed by +$6.75M (+11.77%)

What is Halozyme Therapeutics, Inc. TTM cost of goods sold?

The current TTM cost of goods sold of HALO is $257.29M

What is the all time high TTM cost of goods sold for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high TTM cost of goods sold is $266.13M

What is Halozyme Therapeutics, Inc. TTM cost of goods sold year-on-year change?

Over the past year, HALO TTM cost of goods sold has changed by +$8.61M (+3.46%)
On this page